Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Researchers show that polymerase theta can efficiently convert RNA sequences back into DNA, a feat more common in viruses than eukaryotic cells. Editor's Note: Thomas Jefferson University issued the ...

Although something that’s taken for granted these days, the ability to perform floating-point operations in hardware was, for the longest time, something reserved for people with big wallets. This ...

TIOBE Index for January 2026: Top 10 Most Popular Programming Languages Your email has been sent January’s TIOBE Index begins the year with familiar names still setting the pace, but the underlying ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Rory Evans Rory Evans is a writer focused on skin-care and beauty products.

One skate trick. One video. One big problem. When Misha lands a trick at the skatepark, her friends film it on their phones. It’s meant to be fun… until an edited version of the video suddenly appears ...

Hear from presidents and first ladies, and learn about their politics, policies, and legacies. Discover the people and events that document the American story — Saturdays on C-SPAN2. Come along with ...

Kaitlin Sullivan is a health and science journalist based in Colorado. She's been part of multiple award-winning investigations into health topics including the international medical device industry ...